SINTX Technologies, Inc.
SALT LAKE City, Oct. 05, 2020 (Globe NEWSWIRE) — SINTX Systems, Inc. (www.SINTX.com) (NASDAQ: SINT), an primary devices producer (OEM) ceramics firm focused on silicon nitride and its applications, introduced these days that Michael Marcroft has been appointed Vice President of Company Enhancement. In this function, Mr. Marcroft will direct company improvement initiatives inside the professional medical gadget sector.
With approximately two a long time of practical experience in clinical technologies organization growth & marketing and advertising, Mr. Marcroft has formerly held positions at 3M, Medtronic, and Boston Scientific. He most recently served as Vice President of Advertising at Vision Supply, exactly where he led quite a few important initiatives.
“We are psyched to have Michael be part of the SINTX crew and really feel like his experiences in the medical product business will assist us get advantage of the wide purposes of silicon nitride,” explained Dr. Sonny Bal, President and CEO of SINTX Systems. “Silicon nitride is the perfect biomaterial and we are self-confident in Michael opening new doors for us across a variety of markets.”
“I am thrilled to be signing up for these an awesome crew and group,” reported Michael Marcroft. “With the achievements SINTX has seasoned in the spine market place, this biomaterial has huge potential in quite a few diverse medical segments together with arthroplasty and dental implants.”
Mr. Marcroft joins Don Bray, Vice President of Organization Progress for the industrial sector and antipathogenic purposes, as the company’s company development management.
About SINTX Systems
SINTX Technologies is an OEM ceramics company that develops and commercializes silicon nitride for clinical and non-healthcare apps. The core strength of SINTX Technologies is the producing, exploration, and advancement of silicon nitride ceramics for exterior associates. The Firm presently manufactures silicon nitride powders and parts in its Food and drug administration registered and ISO 13485:2016 accredited production facility.
For far more information on SINTX Technologies or its silicon nitride substance platform, please visit www.sintx.com.
This press launch consists of ahead-seeking statements inside of the meaning of the Personal Securities Litigation Reform Act of 1995 (PSLRA) that are subject matter to a range of challenges and uncertainties. Threats and uncertainties that may induce these types of variances involve, amongst other matters:incorporation of silicon nitride into own protecting tools may well not be safe and sound or productive volatility in the rate of SINTX’s prevalent inventory the uncertainties inherent in new solution advancement, which includes the price tag and time demanded to commercialize these kinds of product(s) industry acceptance of our items once commercialized SINTX’s ability to raise more funding and other competitive developments. Audience are cautioned not to put undue reliance on the ahead-wanting statements, which communicate only as of the day on which they are designed and replicate management’s latest estimates, projections, anticipations and beliefs. There can be no assurance that any of the anticipated benefits will come about on a well timed foundation or at all because of to particular risks and uncertainties, a dialogue of which can be found in SINTX’s Threat Factors disclosure in its Annual Report on Kind 10-K, submitted with the Securities and Trade Commission (SEC) on March 26, 2020, and in SINTX’s other filings with the SEC. SINTX disclaims any obligation to update any forward-on the lookout statements. SINTX undertakes no obligation to publicly revise or update the ahead-on the lookout statements to mirror occasions or instances that occur immediately after the day of this report.
Business enterprise Inquiries for SINTX: